Are Cell and Gene Therapy Innovations Ready for Widespread Use?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

Treatment of diseases like cancer and HIV is hitting a new frontier with cell-based therapy. This new therapy invigorates the medical world, but it’s not widely accessible yet. Discussing the breakthroughs in these treatments, I Don’t Care host Kevin Stevenson spoke with immunologist Dr. Chris Xu, CEO of ThermoGenesis, a medical device company that’s a pioneer in the field.

“Cell-based therapy came about 13 years ago, and we’ve been fostering the field around cord blood, with 90% of FDA approved cord blood stored in a nitrogen system we developed,” Dr. Xu explained.

That was the company’s beginning, but it has aspirations to do much more. That requires a shift in treatment perspective. “We’ve long used drugs to treat illnesses, but cancer is much more complex. The newly approved therapy takes a patient’s T-cells, which are part of the immune system. It reprograms them to recognize cancer and fight it. It’s the future of medicine,” Dr. Xu said.

“Using someone’s T-cells turns their body into the best defense mechanism against disease.” – Dr. Chris Xu

Thus far, Dr. Xu reported that patients with leukemia and lymphomas have a 93% response rate. He also noted that cancer treatment is just the beginning. Over 1200 trials targeting every type of cancer are ongoing.

HIV is another disease where cell gene therapy has promise. “We discovered that a small percentage of the population doesn’t carry the receptor for HIV, which is necessary for the virus to enter a cell. We can modify cells not to have it, making the patient HIV resistant.”

While the promise of new treatments is here, Dr. Xu noted there are two big impediments. One is cost, with treatments costing as much as $500,000. The other is that patients may no longer have T-cells due to radiation, chemo, or other issues. That’s why he recommends storing cord blood for future use.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Investment
Business Investment in Solar and Battery Storage
October 21, 2025

Commercial and industrial electrical rates are rising, and this trend is expected to accelerate due to the massive energy demands from new data centers supporting the AI industry. For example, the Texas electrical grid is projected to need to double its capacity by 2030 to meet this new demand. This significant capital investment…

Read More
cardiovascular
Technology Is Transforming Cardiovascular Care But Can Access Keep Up?
October 21, 2025

Cardiovascular care is entering one of its most transformative periods in decades. Advances in AI imaging and minimally invasive procedures are transforming the diagnosis and treatment of heart disease. According to the World Health Organization, an estimated 19.8 million people died from cardiovascular diseases in 2022, representing approximately 32% of all global deaths. This…

Read More
rural healthcare
Hot Takes on Rural Healthcare: Lessons from the Frontlines of a System in Decline
October 21, 2025

Across America, rural hospitals are facing an existential crisis. From physician burnout and recruitment struggles to malpractice insurance woes and shrinking OB units, the challenges facing small health systems are multiplying. According to the National Rural Health Association, roughly 190 rural hospitals have closed down or discontinued inpatient care since 2010 — and many more…

Read More
private schools
Protecting Private Schools and Faith-Based Communities
October 21, 2025

School Safety Today podcast, presented by Raptor Technologies. In this episode of School Safety Today, host Dr. Amy Grosso speaks with Adam Coughran, founder of Safe Kids, Inc., about how private and faith-based schools can strengthen safety practices despite limited resources. KEY POINTS: Physical systems, community engagement, and knowledge must work together for effective…

Read More